BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xiao W, Yao E, Zheng W, Tian F, Tian L. miR-337 can be a key negative regulator in melanoma. Cancer Biol Ther 2017;18:392-9. [PMID: 28498028 DOI: 10.1080/15384047.2017.1323581] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Razavi ZS, Tajiknia V, Majidi S, Ghandali M, Mirzaei HR, Rahimian N, Hamblin MR, Mirzaei H. Gynecologic cancers and non-coding RNAs: Epigenetic regulators with emerging roles. Crit Rev Oncol Hematol 2021;157:103192. [PMID: 33290823 DOI: 10.1016/j.critrevonc.2020.103192] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 12.5] [Reference Citation Analysis]
2 Ma Y, Duan J, Hao X. Down-regulated HDAC3 elevates microRNA-495-3p to restrain epithelial-mesenchymal transition and oncogenicity of melanoma cells via reducing TRAF5. J Cell Mol Med 2020;24:12933-44. [PMID: 33048450 DOI: 10.1111/jcmm.15885] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zhang Z, Zhang L, Wang B, Wei R, Wang Y, Wan J, Zhang C, Zhao L, Zhu X, Zhang Y, Chu C, Guo Q, Yin X, Li X. MiR-337-3p suppresses proliferation of epithelial ovarian cancer by targeting PIK3CA and PIK3CB. Cancer Lett 2020;469:54-67. [PMID: 31629932 DOI: 10.1016/j.canlet.2019.10.021] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
4 Shi J, Su Q, Han F, Chen W, Zhang D, Xu B. MiR-337 suppresses pancreatic cancer development via STAT3/Wnt/β-catenin axis. Anticancer Drugs 2021;32:681-92. [PMID: 33587353 DOI: 10.1097/CAD.0000000000001044] [Reference Citation Analysis]
5 Ghafouri-Fard S, Gholipour M, Taheri M. MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets. Front Oncol 2021;11:608987. [PMID: 33968718 DOI: 10.3389/fonc.2021.608987] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Xia L, Wu L, Xia H, Bao J, Li Q, Chen X, Xia R. miR-337 suppresses cutaneous T-cell lymphoma via the STAT3 pathway. Cell Cycle 2019;18:1635-45. [PMID: 31213131 DOI: 10.1080/15384101.2019.1629789] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Sun M, Ma X, Tu C, Wang X, Qu J, Wang S, Xiao S. MicroRNA-378 regulates epithelial-mesenchymal transition and metastasis of melanoma by inhibiting FOXN3 expression through the Wnt/β-catenin pathway. Cell Biol Int 2019;43:1113-24. [PMID: 29972255 DOI: 10.1002/cbin.11027] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
8 Pan Y, Zhao Y, Lihui L, Xie Y, Zou Q. MiR-337-3p suppresses migration and invasion of breast cancer cells by downregulating ESRP1. Acta Histochem 2021;123:151777. [PMID: 34481218 DOI: 10.1016/j.acthis.2021.151777] [Reference Citation Analysis]